NEUROLOGICAL ASSESSMENT of COMA David E Bateman *I13
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Tactics of Family Doctors in Case of Syncopal States
MINISTRY OF PUBLIC HEALTH OF UKRAINE ZAPORIZHZHIA STATE MEDICAL UNIVERSITY DEPARTMENT OF GENERAL PRACTICE – FAMILY MEDICINE AND INTERNAL DISEASES DEPARTMENT OF GENERAL PRACTICE – FAMILY MEDICINE, THERAPY, CARDIOLOGY AND NEUROLOGY OF THE POSTGRADUATE FACULTY TACTICS OF FAMILY DOCTORS IN CASE OF SYNCOPAL STATES STUDY GUIDE for the students of the specialty "Medicine" in the program of the educational discipline "General Practice - Family Medicine" Zaporizhzhia 2020 2 UDC 616.8-009.832-08(072) М 99 Аpproved by Central Methodical Council of Zaporizhzhia State Medical University as а study guide (Protocol № 3 of 27.02.2020) and recommended for use in the educational process Authors: N. S. Mykhailovska - Doctor of Medical Sciences, Professor, head of the Department of General practice – family medicine and internal diseases, Zaporizhzhia State Medical University; A. V. Grytsay - PhD, associated professor of the Department of General practice – family medicine and internal diseases, Zaporizhzhia State Medical University; І. S. Kachan - associated professor of the Department of Family medicine, therapy, cardiology and neurology of the Postgraduate faculty, Zaporizhzhia State Medical University. Readers: S. Y. Dotsenko – Doctor of Medical Sciences, Professor, Head of the Internal Medicine №3 Department, Zaporozhye State Medical University; S. M. Kiselev – Doctor of Medical Sciences, Professor, Professor of the Department of Internal diseases 1, Zaporizhzhia State Medical University. Mykhailovska N. S. M99 Tactics of family doctors in case of syncopal states = Тактика сімейного лікаря при синкопальних станах: study guide for the practical classes and individual work for 6th-years students of international faculty (speciality «General medicine»), discipline «General practice – family medicine» / N. S. Mykhailovska, A. V. Grytsay, I.S. -
Acute Stress Disorder
Trauma and Stress-Related Disorders: Developments for ICD-11 Andreas Maercker, MD PhD Professor of Psychopathology, University of Zurich and materials prepared and provided by Geoffrey Reed, PhD, WHO Department of Mental Health and Substance Abuse Connuing Medical Educaon Commercial Disclosure Requirement • I, Andreas Maercker, have the following commercial relaonships to disclose: – Aardorf Private Psychiatric Hospital, Switzerland, advisory board – Springer, book royales Members of the Working Group • Christopher Brewin (UK) Organizational representatives • Richard Bryant (AU) • Mark van Ommeren (WHO) • Marylene Cloitre (US) • Augusto E. Llosa (Médecins Sans Frontières) • Asma Humayun (PA) • Renato Olivero Souza (ICRC) • Lynne Myfanwy Jones (UK/KE) • Inka Weissbecker (Intern. Medical Corps) • Ashraf Kagee (ZA) • Andreas Maercker (chair) (CH) • Cecile Rousseau (CA) WHO scientists and consultant • Dayanandan Somasundaram (LK) • Geoffrey Reed • Yuriko Suzuki (JP) • Mark van Ommeren • Simon Wessely (UK) • Michael B. First WHO Constuencies 1. Member Countries – Required to report health stascs to WHO according to ICD – ICD categories used as basis for eligibility and payment of health care, social, and disability benefits and services 2. Health Workers – Mulple mental health professions – ICD must be useful for front-line providers of care in idenfying and treang mental disorders 3. Service Users – ‘Nothing about us without us!’ – Must provide opportunies for substanve, early, and connuing input ICD Revision Orienting Principles 1. Highest goal is to help WHO member countries reduce disease burden of mental and behavioural disorders: relevance of ICD to public health 2. Focus on clinical utility: facilitate identification and treatment by global front-line health workers 3. Must be undertaken in collaboration with stakeholders: countries, health professionals, service users/consumers and families 4. -
ICD-11 Diagnostic Guidelines Stress Disorders 2020 07 21
Pre-Publication Draft; not for citation or distribution 1 ICD-11 DIAGNOSTIC GUIDELINES Disorders Specifically Associated with Stress Note: This document contains a pre-publication version of the ICD-11 diagnostic guidelines for Disorders Specifically Associated with Stress. There may be further edits to these guidelines prior to their publication. Table of Contents DISORDERS SPECIFICALLY ASSOCIATED WITH STRESS ...................................... 2 6B40 Post-Traumatic Stress Disorder ............................................................................ 3 6B41 Complex Post-Traumatic Stress Disorder ............................................................. 8 6B42 Prolonged Grief Disorder .................................................................................... 12 6B43 Adjustment Disorder ........................................................................................... 15 6B44 Reactive Attachment Disorder ............................................................................ 17 6B45 Disinhibited Social Engagement Disorder .......................................................... 20 6B4Y Other Specified Disorders Specifically Associated with Stress ......................... 22 QE84 Acute Stress Reaction ......................................................................................... 23 © WHO Department of Mental Health and Substance Abuse 2020 Pre-Publication Draft; not for citation or distribution 2 DISORDERS SPECIFICALLY ASSOCIATED WITH STRESS Disorders Specifically Associated with Stress -
Recovery from Disorders of Consciousness: Mechanisms, Prognosis and Emerging Therapies
REVIEWS Recovery from disorders of consciousness: mechanisms, prognosis and emerging therapies Brian L. Edlow 1,2, Jan Claassen3, Nicholas D. Schiff4 and David M. Greer 5 ✉ Abstract | Substantial progress has been made over the past two decades in detecting, predicting and promoting recovery of consciousness in patients with disorders of consciousness (DoC) caused by severe brain injuries. Advanced neuroimaging and electrophysiological techniques have revealed new insights into the biological mechanisms underlying recovery of consciousness and have enabled the identification of preserved brain networks in patients who seem unresponsive, thus raising hope for more accurate diagnosis and prognosis. Emerging evidence suggests that covert consciousness, or cognitive motor dissociation (CMD), is present in up to 15–20% of patients with DoC and that detection of CMD in the intensive care unit can predict functional recovery at 1 year post injury. Although fundamental questions remain about which patients with DoC have the potential for recovery, novel pharmacological and electrophysiological therapies have shown the potential to reactivate injured neural networks and promote re-emergence of consciousness. In this Review, we focus on mechanisms of recovery from DoC in the acute and subacute-to-chronic stages, and we discuss recent progress in detecting and predicting recovery of consciousness. We also describe the developments in pharmacological and electro- physiological therapies that are creating new opportunities to improve the lives of patients with DoC. Disorders of consciousness (DoC) are characterized In this Review, we discuss mechanisms of recovery by alterations in arousal and/or awareness, and com- from DoC and prognostication of outcome, as well as 1Center for Neurotechnology mon causes of DoC include cardiac arrest, traumatic emerging treatments for patients along the entire tempo- and Neurorecovery, brain injury (TBI), intracerebral haemorrhage and ral continuum of DoC. -
Unarousable Unresponsiveness in Which the Patient Lies with the Eye Closed and Has No Awareness of Self and Surroundings (2)
Neurological Disease Deborah M Stein, MD, MPH 1. Coma a. Coma is defined as “a state of extreme unresponsiveness, in which an individual exhibits no voluntary movement or behavior” (1). i. Alternatively, coma is a state of unarousable unresponsiveness in which the patient lies with the eye closed and has no awareness of self and surroundings (2). b. Coma lies on a spectrum with other alterations in consciousness – from confusion to delirium to obtundation to stupor to coma and, ultimately, brain death (2). c. To be clearly distinguished from syncope, concussion, or other states of transient unconsciousness coma must persist for at least one hour (2). d. There are 2 important characteristics of the conscious state (3) i. The level of consciousness – “arousal or wakefulness” 1. Regulated by physiological functioning and consists of more primitive responsiveness to the world such as predictable involuntary reflex responses to stimuli. 2. Arousal is maintained by the reticular activating system (RAS) - a network of structures (including the brainstem, the medulla, and the thalamus) ii. The content of consciousness – “awareness” 1. Regulated by cortical areas within the cerebral hemispheres, e. There are two main causes for coma: i. Bihemispheric diffuse cortical or white matter damage or ii. Brainstem lesions bilaterally affecting the subcortical reticular activating systems. f. A huge number of conditions can result in coma. One way to categorize these conditions is to divide them into the anatomic and the metabolic causes of coma. i. Anatomic causes of coma are those conditions that disrupt the normal physical architecture and anatomy, either at the level of the cerebral cortex or the brainstem ii. -
Heat Illness & Hydration
Sideline Emergencies: Exertional Heat Illness- Prevention and Treatment Updates AOSSM: 2019 Sports Medicine & Football - Youth to the NFL Damion A. Martins, MD Medical Director of Sports Medicine Sports Medicine Fellowship Program Director, Atlantic Health Systems Director of Internal Medicine, New York Jets DISCLOSURE Neither I, (Damion Martins, MD), nor any family member(s), author(s), have any relevant financial relationships to be discussed, directly or indirectly, referred to or illustrated with or without recognition within the presentation. Learning Objectives Describe the pathophysiology of Exertional Heat Illness Identify signs and symptoms of Exertional Heat Stroke Understand urgent on the field management and treatment of Heat Illness Understand current evidence for prevention and treatment of Exertional Heat Stroke Overview Heat Illness – Diagnosis – Pathophysiology – Risk Factors – Evaluation / Treatment Hydration – NCAA / NFL data – IV vs PO data McNair video 6 Physiology Thermoregulation Production Dissipation – – basal metabolism conduction – – exercise radiation – convection – evaporation Sandor RP. Phys SportsMed. 1997;25(6):35-40. Heat Illness Spectrum Heat Illness Heat Injury Heat Stroke Definitions Exertional Heat Illness (EHI) Heat edema – initial days of heat exposure – self-limited, mild swelling of hands / feet Heat cramps or Exercise Associated Muscle Cramps (EAMCs) – skeletal muscle cramping during or after exercise – usually abdominal and extremities Heat syncope – orthostatic dizziness or sudden -
Neurologic Manifestations of Hypoglycemia
13 Neurologic Manifestations of Hypoglycemia William P. Neil and Thomas M. Hemmen University of California, San Diego United States of America (USA) 1. Introduction Unlike most other body tissues, the brain requires a continuous supply of glucose. It has very limited endogenous glycogen stores, and does not produce glucose intrinsically.1 Although it accounts for 2% of body weight, the brain utilizes 25% of the body’s glucose due to its high metabolic rate.2, 3 Evidence for the brains sole reliance on glucose came from obtaining a respiratory quotient of one after measuring differences between arterial and venous content of oxygen and carbon dioxide in blood traveling through the brain.4 In the past, neurons were thought to directly metabolize glucose, however, more recent studies suggest astrocytes may play an important role in glucose metabolism.5 Astrocytic foot processes surround brain capillaries, which deliver glucose to the brain. With this, they form the first cellular barrier for entering glucose.5 Astrocytes contain the non-insulin dependent GLUT1 transporter, as well as the insulin dependent GLUT4 transporter, suggesting a possible role for astrocytes in regulating and storing brain glucose in an insulin dependent and independent manner (see figure 1).6-8 In addition to glucose, the brain contains a very limited store of glycogen, (between 0.5 and 1.5 g, or about 0.1% of total brain weight). Unlike peripheral tissue, where glycogen is readily mobilized during hypoglycemia, the brain can only function normally for a limited duration. Glycogen content seems to fall in areas of highest brain metabolic rate, suggesting at least some, albeit limited role as fuel during hypoglycemia.7 Although the brain relies primarily on glucose during normal conditions, it can use ketone bodies during starvation. -
Public Comment 8
www.JazzPharmaceuticals.com May 20, 2021 Priya Shah West Virginia Medicaid 350 Capitol Street, Room 251 Charleston WV 25301 Dear Priya Shah, Thank you for your request for information regarding XYWAV™ (calcium, magnesium, potassium, and sodium oxybates) oral solution. If you did not specifically request the enclosed information, please contact Jazz Medical Information at 1-800-520-5568. XYWAV is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. Below is the information you requested. • XYWAV (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Written Comments for Medicaid • XYWAV Prescribing Information Please refer to the accompanying XYWAV™ full Prescribing Information including the Boxed Warning. This information is provided to you as a professional courtesy and may include content that has not been approved by the United States Food and Drug Administration (FDA). Statements in this communication are not intended to advocate any indication, dosage, or other claim not set forth in the prescribing information. This response contains information of a general nature and is intended solely to assist you in formulating your own conclusions regarding our product. It is not meant to be a thorough review of the literature and does not represent all professional points of view on this subject. Thank you for your interest in XYWAV™. Please contact Medical Information at 1-800-520-5568 if you have further questions. Sincerely, Jazz Pharmaceuticals -
Postconcussional Disorder and Loss of Consciousness
Postconcussional Disorder and Loss of Consciousness Stephen D. Anderson, MD, FRCP(C) Postconcussional disorder (PCD) has been described in the psychiatric, neuro- logical, neuropsychological, and rehabilitation medicine literature for many years. PCD has recently been introduced into DSM-IV, appearing in an appendix that contains a number of proposals for new categories and axes that were suggested for possible inclusion in DSM-IV. There are some major difficulties with the proposed criteria for PCD. This article explores some of these difficulties, partic- ularly focusing on the criteria of loss of consciousness (LOC). A review of the literature demonstrates that LOC is not necessary for PCD to occur. The major difficulty with the DSM-IV criteria is the definition of concussion. The article suggests that, instead, the criteria for mild traumatic brain injury, as defined by the American Congress of Rehabilitation Medicine, may be more appropriate. Postconcussional disorder (PCD) has been symptoms include headache pain, nausea. described in the medical literature for dizziness or vertigo. unsteadiness or poor over a century. The telm Post-concussion coordination, tinnitus, hearing loss. blurred syndrome was coined by Strauss and vision, diplopia, convergence insufficiency. Savitsky in 1934.' PCD is the most preva- light and noise sensitivity, and altered sense lent and yet controversial neuropsychiat~ic of taste and smell. The cognitive deficits diagnosis following brain injury. PCD is include memory difticulties, decreased at- linked most commonly to minor brain in- tention and concentration, decreased speed jury. because the symptoms are unobscured of information processing, communication by the myriad of findings that accompany a difficulties, difficulties with executive fin- more severe brain injuly. -
Current Clinical Approach to Patients with Disorders of Consciousness
CURRENTREVIEW CLINICAL APPROA CARTICLEH TO PATIENTS WITH DISORDERS OF CONSCIOUSNESS Current clinical approach to patients with disorders of consciousness ROBSON LUIS OLIVEIRA DE AMORIM1, MARCIA MITIE NAGUMO2*, WELLINGSON SILVA PAIVA3, ALMIR FERREIRA DE ANDRADE3, MANOEL JACOBSEN TEIXEIRA4 1PhD – Assistant Physician of the Neurosurgical Emergency Unit, Division of Neurosurgery, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil 2Nurse – MSc Student at the Neurosurgical Emergency Unit, Division of Neurosurgery, Hospital das Clínicas, FMUSP, São Paulo, SP, Brazil 3Habilitation (BR: Livre-docência) – Professor of the Neurosurgical Emergency Unit, Division of Neurosurgery, Hospital das Clínicas, FMUSP, São Paulo, SP, Brazil 4Habilitation (BR: Livre-docência) – Full Professor of the Division of Neurosurgery, Hospital das Clínicas, FMUSP, São Paulo, SP, Brazil SUMMARY Study conducted at Hospital das Clínicas, In clinical practice, hospital admission of patients with altered level of conscious- Faculdade de Medicina, Universidade de ness, sleepy or in a non-responsive state is extremely common. This clinical con- São Paulo (FMUSP), São Paulo, SP, Brazil dition requires an effective investigation and early treatment. Performing a fo- Article received: 1/28/2015 cused and objective evaluation is critical, with quality history taking and Accepted for publication: 5/4/2015 physical examination capable to locate the lesion and define conducts. Imaging *Correspondence: and laboratory exams have played an increasingly important role in supporting Address: Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César clinical research. In this review, the main types of changes in consciousness are São Paulo, SP – Brazil discussed as well as the essential points that should be evaluated in the clinical Postal code: 05403-000 [email protected] management of these patients. -
Xyrem (Sodium Oxybate) Is a CNS Depressant
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Important Administration Information for All Patients XYREM safely and effectively. See full prescribing information for • Take each dose while in bed and lie down after dosing (2.3). XYREM. • Allow 2 hours after eating before dosing (2.3). • Prepare both doses prior to bedtime; dilute each dose with approximately ¼ XYREM® (sodium oxybate) oral solution, CIII cup of water in pharmacy-provided containers (2.3). Initial U.S. Approval: 2002 • Patients with Hepatic Impairment: starting dose is one-half of the original dosage per night, administered orally divided into two doses (2.4). • WARNING: CENTRAL NERVOUS SYSTEM (CNS) DEPRESSION Concomitant use with Divalproex Sodium: an initial reduction in Xyrem dose and ABUSE AND MISUSE. of at least 20% is recommended (2.5, 7.2). --------------------DOSAGE FORMS AND STRENGTHS------------------- See full prescribing information for complete boxed warning. Oral solution, 0.5 g per mL (3) Central Nervous System Depression ----------------------------CONTRAINDICATIONS------------------------------ • Xyrem is a CNS depressant, and respiratory depression can occur with • In combination with sedative hypnotics or alcohol (4) Xyrem use (5.1, 5.4) • Succinic semialdehyde dehydrogenase deficiency (4) Abuse and Misuse • Xyrem is the sodium salt of gamma-hydroxybutyrate (GHB). Abuse or misuse of illicit GHB is associated with CNS adverse reactions, ---------------------WARNINGS AND PRECAUTIONS---------------------- -
Syncope: Overview and Approach to Management
SMAC01 01/21/2005 09:57 AM Page 1 1 CHAPTER 1 Syncope: Overview and approach to management Brian Olshansky, MD “near-syncope”), falling episodes, and coma are Introduction often confused with, and inappropriately labeled Syncope is a common, important medical problem as, “true” syncope. Distinction between sleeping, caused by many conditions, ranging from benign confusion, intoxication, and fainting may not be and self-limiting to chronic, recurrent, and poten- completely clear. To make matters more difficult, tially fatal causes. Unfortunately, differentiation an elderly patient, already confused, may fall and between benign and malignant causes can be diffi- pass out with only vague recall of the event. Such a cult and challenging. Even with knowledge of com- patient may even think he or she passed out when mon syndromes and conditions that cause syncope, nothing of the sort occurred. This diverse collec- and guidelines [1], an effective approach to the tion of clinical presentations perplexes the patient problem requires careful integration of clues pro- and the physician. Episodes can be difficult to define vided in the history and physical examination com- even with careful observation, and the mechanism bined with keen clinical acumen. Management of may be confusing even with extensive monitoring. this baffling problem can be frustrating, confusing, True syncope is an abrupt but transient loss of and often unrewarding. Treatment can be imposs- consciousness associated with absence of postural ible to prescribe without a clear understanding of tone followed by rapid, usually complete, recovery the cause, and treatments may be directed to risk as without the need for intervention to stop the epis- well as symptom reduction.